CliffBio
small molecule

ZESTORETIC

HYDROCHLOROTHIAZIDE; LISINOPRIL

Loss of exclusivity—loss of exclusivity
CompanyAlmatica Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameZESTORETIC
Active ingredientHYDROCHLOROTHIAZIDE; LISINOPRIL
Strength12.5MG;10MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalNovember 1993
Marketing statusRX

More from Almatica Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.